Alexium International Group’s prototype foam mattresses using FR socks treated with Alexiflam NF have cleared independent flammability tests. These tests are required by US federal safety standards in 16 CFR 1633. Alexium is a performance chemicals provider for advanced materials applications with a focus on flame retardancy and thermal management.
Underwriter Laboratories (UL), an independent third party, conducted the testing. As regulated by the United States Consumer Product Safety Commission, the UL testing confirmed that the barrier treated with Alexiflam NF met all regulatory requirements and passed the rigorous flammability test protocol. Flame-retardant treatments reduce the chances of a fire starting and delay the spread of fire once it starts.
“Current FR sock solutions use fibreglass technology to pass fire standards,” said Allen Reihman, Alexium’s chief commercial officer. “Consumers are concerned with the health effects of shards of tiny glass that can migrate through the home.”
Mattress suppliers and brands are seeking solutions to this problem, and socks treated with Alexiflam NF contain no fibreglass. By treating natural cotton instead of synthetic materials, Alexiflam NF provides a solution that is both sustainable and safe. Moreover, Alexiflam NF solutions are more affordable than fibreglass alternatives.
“Passing this critical safety test is a major milestone in our commercialisation of Alexiflam NF and validates our unwavering focus on innovation,” said Dr. Robert Brookins, Alexium chief executive officer. “We’re progressing according to our growth plan by demonstrating our ability to successfully bring new product solutions to market quickly that align with customer needs. At this stage Alexium will begin working with new and existing customers on how they can use the FR cotton socks in their product lines.”
Fibre2Fashion News Desk (SV)